Toggle navigation
Home
People
Departments
Research
About
Login
Search
A Phase 3 Prospective, Randomized, Partially Blinded Multi-Center Study to Measure the Safety and Efficacy of NOVOCART 3D Compared to Microfracture in the Treatment of Articular Cartilage Defects
Grant
Overview
Affiliation
View All
Overview
date/time interval
2018 - 2025
awarded by
Aesculap Biologics
total award amount
USD 399000
Affiliation
contributor
Khan, Moin
Principal Investigator